SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+4.44%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$459M
AUM Growth
+$459M
(-8.9%)
Cap. Flow
-$53.2M
Cap. Flow
% of AUM
-11.6%
Top 10 Holdings %
Top 10 Hldgs %
60.52%
Holding
51
New
14
Increased
5
Reduced
22
Closed
10
Top Buys
| 1 |
Eli Lilly
LLY
|
$47.4M |
| 2 |
Sanofi
SNY
|
$46.2M |
| 3 |
Abbott
ABT
|
$30.6M |
| 4 |
Biogen
BIIB
|
$24.6M |
| 5 |
Centene
CNC
|
$12.3M |
Top Sells
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$83.5M |
| 2 |
AGN
Allergan plc
AGN
|
$38.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$29.9M |
| 4 |
Amgen
AMGN
|
$17.2M |
| 5 |
Travere Therapeutics
TVTX
|
$14M |
Sector Composition
| 1 | Healthcare | 90.06% |
| 2 | Financials | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $47.4M | 10.33% | +601,800 | New | +$47.4M |
|
|
2
Sanofi
SNY
$121B
| $46.2M | 10.06% | +1,103,300 | New | +$46.2M |
|
|
3
Abbott
ABT
$231B
| $30.6M | 6.67% | +778,900 | New | +$30.6M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $30M | 6.55% | 163,200 +42,500 | +35% | +$7.82M |
|
|
5
Biogen
BIIB
$19.4B
| $24.6M | 5.35% | +101,600 | New | +$24.6M |
|
|
6
Amgen
AMGN
$155B
| $23.7M | 5.17% | 155,932 -113,368 | -42% | -$17.2M |
|
|
TVTY
7
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $21.1M | 4.6% | 1,827,829 -393,652 | -18% | -$4.55M |
|
|
AET
8
DELISTED
Aetna Inc
AET
| $19.9M | 4.33% | 162,700 -37,300 | -19% | -$4.56M |
|
9
Elevance Health
ELV
$71.8B
| $18.9M | 4.12% | 143,800 -60,900 | -30% | -$8M |
|
10
Universal Health Services
UHS
$11.6B
| $15.4M | 3.35% | 114,700 +25,200 | +28% | +$3.38M |
|
|
11
Centene
CNC
$14.3B
| $12.3M | 2.69% | +172,800 | New | +$12.3M |
|
12
Labcorp
LH
$23.1B
| $11.3M | 2.46% | 86,800 -40,000 | -32% | -$5.21M |
|
13
Enanta Pharmaceuticals
ENTA
$180M
| $10.6M | 2.32% | 482,000 +143,149 | +42% | +$3.16M |
|
|
ELGX
14
DELISTED
Endologix Inc
ELGX
| $10.1M | 2.2% | +809,800 | New | +$10.1M |
|
|
ACOR
15
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $9.14M | 1.99% | 358,191 +173,289 | +94% | +$4.42M |
|
|
CNCE
16
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $8.99M | 1.96% | 800,788 -670,905 | -46% | -$7.53M |
|
|
MNTA
17
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $8.73M | 1.9% | 808,198 -391,693 | -33% | -$4.23M |
|
|
ALDR
18
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $8.47M | 1.84% | 339,070 -174,500 | -34% | -$4.36M |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $7.93M | 1.73% | +94,300 | New | +$7.93M |
|
20
Insmed
INSM
$28.8B
| $7.78M | 1.69% | 788,936 -316,062 | -29% | -$3.12M |
|
21
Molina Healthcare
MOH
$9.8B
| $7.52M | 1.64% | +150,700 | New | +$7.52M |
|
22
Halozyme
HALO
$8.56B
| $6.78M | 1.48% | +785,744 | New | +$6.78M |
|
|
CORI
23
DELISTED
Corium International, Inc.
CORI
| $6.03M | 1.31% | 1,736,466 +500 | +0% | +$1.74K |
|
|
24
Travere Therapeutics
TVTX
$1.56B
| $5.87M | 1.28% | 329,489 -785,103 | -70% | -$14M |
|
25
Acadia Healthcare
ACHC
$2.12B
| $5.67M | 1.24% | +102,400 | New | +$5.67M |
|